Japanese Journal of Medical Science and Biology · 1990 · 20 citations · 11 references
MedicineImmunologyInfectious DiseasesHepatologyMolecular VirologyVirologyHepatic PathologyHepatocellular CarcinomaLiver DiseaseViral HepatitisCdna CloningChronic Viral HepatitisHepatitis C InfectionHepatitis SerologyHepatocellular Carcinoma PathogenesisInfectious Hepatitis
With the antigen expressed in yeast from a cDNA clone encoding a non-structural region of newly discovered hepatitic C virus (HCV) genome, the prevalence of HCV antibody in people in Thailand was investigated. Antibody was detected in 2.6% of healthy blood donors and in 2.8% of healthy pregnant women. These prevalence rates were higher than those reported previously from Japan, USA and European countries. Among community-acquired, sporadic cases of acute and chronic non-A, non-B hepatitis, however, only 5.7% and 15.4% were shown to possess the antibody, respectively. Among hepatocellular carcinoma patients who were negative for hepatitis B surface antigen in the sera, 11.1% had antibody to HCV. These seroepidemiological data suggest that HCV plays an important role as an etiological agent in Thailand; however, other agents must also be involved in etiologic agents of viral hepatitis and chronic liver disease.
11
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Qui‐Lim Choo, George Kuo, Amy J. Weiner et al. · Science · 1989 · 6.9K citations
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
George Kuo, Q L Choo, Harrison Alter et al. · Science · 1989 · 3.4K citations
HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN
L. Viladomiu, Antonio González, M Roget et al. · The Lancet · 1989 · 900 citations
CLINICAL AND SEROLOGICAL ANALYSIS OF TRANSFUSION-ASSOCIATED HEPATITIS
HarveyJ. Alter, P. V. Holland, AndrewG. Morrow et al. · The Lancet · 1975 · 358 citations